Skip to main content
Livermore
Livermore
ZHEN

Celldex Therapeutics, Inc.

CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000744218

No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Celldex Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CLDX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders176174−2
Shares71.8M73.7M+1.88M (+2.6%)
Value$2.44B$1.86B−$578.8M (−23.7%)

New holders (34)

Institutions that held Celldex Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CLDX in Q4 2024
InstitutionSharesValue% of portfolio
Deep Track Capital, LP1,540,132$38.9M1.46%
Vestal Point Capital, LP305,000$7.71M0.46%
Polygon Management Ltd.192,000$4.85M1.57%
Cubist Systematic Strategies, LLC154,512$3.90M0.06%
Renaissance Technologies LLC136,588$3.45M0.01%
Sovran Advisors, LLC113,457$2.60M0.37%
Hudson Bay Capital Management LP45,000$1.14M0.01%
Atom Investors LP39,203$990.7K0.12%
Two Sigma Investments, LP33,025$834.5K0.00%
Tudor Investment Corp Et Al32,545$822.4K0.01%
Tema ETFs LLC29,480$745.0K0.31%
Guggenheim Capital LLC23,797$601.4K0.00%
Bryce Point Capital, LLC23,790$601.2K0.17%
ExodusPoint Capital Management, LP17,244$436.0K0.00%
Jump Financial, LLC16,513$417.3K0.01%
Natixis15,800$399.3K0.00%
Nebula Research & Development LLC14,027$354.5K0.04%
Police & Firemen's Retirement System of New Jersey13,923$351.8K0.00%
KLP Kapitalforvaltning AS12,100$305.8K0.00%
E Fund Management Co., Ltd.10,785$272.5K0.01%
Ameriprise Financial Inc9,944$251.3K0.00%
Phoenix Holdings Ltd.9,615$243.0K0.00%
HSBC Holdings PLC9,292$232.6K0.00%
Aristides Capital LLC8,000$202.2K0.06%
Aquatic Capital Management LLC4,780$120.8K0.00%
Headlands Technologies LLC3,212$81.2K0.01%
R Squared Ltd880$22.2K0.02%
Bayforest Capital Ltd865$21.9K0.03%
Aster Capital Management (DIFC) Ltd190$4.80K0.00%
Skopos Labs, Inc.98$2.48K0.00%
Quadrant Capital Group LLC67$1.69K0.00%
Amundi42$1.11K0.00%
SBI Securities Co., Ltd.30$7580.00%
Allworth Financial LP18$4370.00%

Sold out (36)

Institutions that held Celldex Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CLDX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Commodore Capital LP1,618,937$55.0M
Jennison Associates LLC1,324,410$45.0M
Logos Global Management LP900,000$30.6M
EcoR1 Capital, LLC650,000$22.1M
Emerald Advisers, LLC456,202$15.5M
Marshall Wace, LLP276,728$9.41M
Emerald Mutual Fund Advisers Trust243,795$8.29M
Balyasny Asset Management LLC86,573$2.94M
Artia Global Partners LP75,300$2.56M
Prudential Financial Inc68,471$2.33M
State of New Jersey Common Pension Fund D52,615$1.79M
PFM Health Sciences, LP52,120$1.77M
Man Group plc35,967$1.22M
Y-Intercept (Hong Kong) Ltd30,538$1.04M
AlphaCentric Advisors LLC30,000$1.02M
Magnetar Financial LLC25,513$867.2K
Assenagon Asset Management S.A.20,946$712.0K
Gsa Capital Partners LLP16,114$548.0K
Point72 (DIFC) Ltd14,114$479.7K
Cowen and Company, LLC10,700$363.7K
HighVista Strategies LLC8,981$305.3K
Overbrook Management Corp6,837$232.4K
Panoramic Investment Advisors, LLC6,500$220.9K
Keybank National Association6,356$216.0K
ADAR1 Capital Management, LLC5,000$169.9K
Acadian Asset Management LLC4,591$156.0K
Point72 Asia (Singapore) Pte. Ltd.1,210$41.1K
SRS Capital Advisors, Inc.139$4.72K
Quantbot Technologies LP95$3.23K
Versant Capital Management, Inc92$3.13K
Creative Financial Designs Inc83$2.82K
Ronald Blue Trust, Inc.59$2.18K
Bessemer Group Inc60$2.00K
Umb Bank N A2$68
Assetmark, Inc1$34
Householder Group Estate & Retirement Specialist, LLC11$0